Related Experiment Video
Updated: Feb 24, 2026
09:48
Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques
Published on: June 30, 2017
7.9K
Cancer, comorbidity and workplace discrimination: The US experience
Amanda K Gehrke1, Michael Feuerstein1,2
1Department of Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
European Journal of Cancer Care
|August 16, 2017
Summary
Cancer survivors with comorbidities face more workplace discrimination, especially regarding employment terms. A revised policy showed some success, but challenges persist for those with concurrent health issues.
Area of Science:
- Occupational Health
- Health Services Research
- Oncology
Background:
- Cancer survivors often experience significant work-related challenges.
- Comorbidities exacerbate these challenges, impacting employment stability.
- A revised workplace discrimination policy aimed to address chronic illness needs.
Purpose of the Study:
- To evaluate the effectiveness of a revised workplace discrimination policy for cancer survivors with comorbidities.
- To identify specific types of discrimination faced by this population.
- To assess the impact of comorbidities on discrimination claim outcomes.
Main Methods:
- Analysis of workplace discrimination allegations filed by US cancer survivors (ages 18-64) between 2009-2011 (N=1,291).
- Utilized multivariable logistic regression to compare cancer survivors with and without comorbidities.
- Examined claims related to terms of employment and their outcomes.
Main Results:
- Cancer survivors with comorbidities were more likely to file discrimination claims concerning terms of employment (OR=1.37).
- Claims related to employment terms had higher success rates for cancer survivors, irrespective of comorbidity status (OR=1.44).
- Despite policy revisions, higher rates of employment discrimination were reported by cancer survivors with concurrent health problems.
Conclusions:
- The revised policy did not fully mitigate employment discrimination for cancer survivors with comorbidities.
- Further research is needed to understand underlying mechanisms and develop targeted interventions.
- Mitigating the impact of comorbid conditions on work function is crucial for this population.
Related Concept Videos
02:59Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
01:19Psychoneuroimmunology: Diabetes and Cancer
544
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
544
02:55Stereotypes, Prejudice, and Discrimination
95.7K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
95.7K
01:21Cancer Survival Analysis
796
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
796
02:43Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
02:18Cancer
54.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.8K